Xia, Zengjie http://orcid.org/0000-0002-5977-9691
Prescott, Emily E.
Urbanek, Agnieszka
Wareing, Hollie E.
King, Marianne C.
Olerinyova, Anna
Dakin, Helen http://orcid.org/0000-0003-0571-5892
Leah, Tom
Barnes, Katy A.
Matuszyk, Martyna M.
Dimou, Eleni http://orcid.org/0000-0003-4885-135X
Hidari, Eric http://orcid.org/0000-0002-4777-5239
Zhang, Yu P.
Lam, Jeff Y. L. http://orcid.org/0000-0001-7408-2342
Danial, John S. H.
Strickland, Michael R. http://orcid.org/0000-0002-3899-5651
Jiang, Hong
Thornton, Peter
Crowther, Damian C. http://orcid.org/0000-0001-7791-1396
Ohtonen, Sohvi http://orcid.org/0000-0003-4674-6484
Gómez-Budia, Mireia http://orcid.org/0000-0002-2194-2510
Bell, Simon M.
Ferraiuolo, Laura http://orcid.org/0000-0001-9118-5714
Mortiboys, Heather http://orcid.org/0000-0001-6439-0579
Higginbottom, Adrian
Wharton, Stephen B.
Holtzman, David M. http://orcid.org/0000-0002-3400-0856
Malm, Tarja http://orcid.org/0000-0002-9530-7472
Ranasinghe, Rohan T.
Klenerman, David http://orcid.org/0000-0001-7116-6954
De, Suman http://orcid.org/0000-0003-1675-0773
Article History
Received: 28 February 2024
Accepted: 21 May 2024
First Online: 1 June 2024
Competing interests
: D.M.H. is an inventor on a patent licensed by Washington University to NextCure on anti-apoE antibodies. D.M.H. co-founded and is on the scientific advisory board of C2N Diagnostics, DenaliGenentech, and Cajal Neuroscience. D.M.H. consults for Asteroid. The lab of D.M.H. receives research grants from the National Institutes of Health, Cure Alzheimer’s Fund, Tau Consortium, the JPB Foundation, Good Ventures, the Rainwater Foundation, NextCure, Eli Lilly, and Ionis. D.C.C. and P.T. hold stock in AstraZeneca. All the other authors declare no competing interests.